Cyanobacterial metabolites as promising drug leads against the Mpro and PLpro of SARS-CoV-2: an in silico analysis

A novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) has emerged as the causative agent behind the coronavirus disease 2019 (COVID-19) pandemic. Treatment efforts have been severely impeded due to the lack of specific effective antiviral drugs for the treatment of COVID-asso- ciat...

Descrizione completa

Dettagli Bibliografici

Autore principale:	Roy, Ayan
Natura:	Articolo
Lingua:	inglese
Pubblicazione:	Taylor & Francis 2025
Soggetti:	SARS-CoV-2; cyanobacterial metabolites; molecular docking; drug-likeness; molecular dynamics simulations; MM-PBSA; deoxycylindrospermopsin
Accesso online:	https://repository.auw.edu.bd/handle/123456789/753